Severe combined immunodeficiency: a retrospective single-center study of clinical presentation and outcome in 117 patients - PubMed (original) (raw)
Severe combined immunodeficiency: a retrospective single-center study of clinical presentation and outcome in 117 patients
J L Stephan et al. J Pediatr. 1993 Oct.
Abstract
We carried out a retrospective analysis of 117 patients with severe combined immunodeficiency who were examined in a single center between Jan. 1, 1970, and Jan. 1, 1992, for the purpose of evaluating disease onset, progression, and outcome. The frequency of case referral increased from 8 from 1970 to 1975 to 56 from 1986 to 1991. The most frequent phenotype was T-/B+ (absence of T lymphocytes and presence of B lymphocytes) (n = 51); there were 36 cases of alymphocytosis, 16 of adenosine deaminase deficiency, 13 of Omenn syndrome, and 1 of reticular dysgenesis. Protracted diarrhea and lung infections were the main infectious complications; infection with bacillus Calmette-Guérin occurred in 10 of 28 vaccinated patients, but none of the six recipients of oral polio vaccine subsequently had poliomyelitis. The presence of maternal T cells was suspected or proved in half the patients with alymphocytosis or T-B+ severe combined immunodeficiency but did not occur in the other forms of the disease. Of the 117 patients, 22 died before transplantation could be performed. Adenosine deaminase deficiency and Omenn syndrome were more frequently associated with death before hematopoietic stem cell transplantation was possible. Fetal liver transplantation was successful in 1 of 10 cases. The survival rate among the 30 recipients of bone marrow with identical human leukocyte antigens (HLA) was 80%, with a median follow-up of 129 months; 23 of 25 patients recovered full immune function. The survival rate among the 50 recipients of HLA-haploidentical T cell-depleted bone marrow was 56%, with a mean follow-up of 35 months. Of the latter patients, 10 (35%) still require immunoglobulin substitution. There has been a trend toward improvement in the survival rate of haploidentical bone marrow recipients, presumably because of more effective infection-control measures and better transplantation strategy.
Similar articles
- Hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency.
Buckley RH, Schiff SE, Schiff RI, Markert L, Williams LW, Roberts JL, Myers LA, Ward FE. Buckley RH, et al. N Engl J Med. 1999 Feb 18;340(7):508-16. doi: 10.1056/NEJM199902183400703. N Engl J Med. 1999. PMID: 10021471 Clinical Trial. - Influence of severe combined immunodeficiency phenotype on the outcome of HLA non-identical, T-cell-depleted bone marrow transplantation: a retrospective European survey from the European group for bone marrow transplantation and the european society for immunodeficiency.
Bertrand Y, Landais P, Friedrich W, Gerritsen B, Morgan G, Fasth A, Cavazzana-Calvo M, Porta F, Cant A, Espanol T, Müller S, Veys P, Vossen J, Haddad E, Fischer A. Bertrand Y, et al. J Pediatr. 1999 Jun;134(6):740-8. doi: 10.1016/s0022-3476(99)70291-x. J Pediatr. 1999. PMID: 10356144 Clinical Trial. - Haploidentical bone marrow stem cell transplantation in human severe combined immunodeficiency.
Buckley RH, Schiff SE, Schiff RI, Roberts JL, Markert ML, Peters W, Williams LW, Ward FE. Buckley RH, et al. Semin Hematol. 1993 Oct;30(4 Suppl 4):92-101; discussion 102-4. Semin Hematol. 1993. PMID: 7905667 Review. - Treatment of Omenn syndrome by bone marrow transplantation.
Gomez L, Le Deist F, Blanche S, Cavazzana-Calvo M, Griscelli C, Fischer A. Gomez L, et al. J Pediatr. 1995 Jul;127(1):76-81. doi: 10.1016/s0022-3476(95)70260-1. J Pediatr. 1995. PMID: 7608815 - Bone marrow transplantation in major histocompatibility complex class II deficiency: a single-center study of 19 patients.
Klein C, Cavazzana-Calvo M, Le Deist F, Jabado N, Benkerrou M, Blanche S, Lisowska-Grospierre B, Griscelli C, Fischer A. Klein C, et al. Blood. 1995 Jan 15;85(2):580-7. Blood. 1995. PMID: 7812013 Review.
Cited by
- Predictive Model for Occurrence of Febrile Neutropenia after Chemotherapy in Patients with Diffuse Large B-Cell Lymphoma: A Multicenter, Retrospective, Observational Study.
Morimoto M, Yokoya Y, Yoshida K, Kosako H, Hori Y, Mushino T, Tamura S, Ito R, Koyamada R, Yamashita T, Mori S, Mori N, Ohde S. Morimoto M, et al. Hematol Rep. 2024 Feb 7;16(1):76-88. doi: 10.3390/hematolrep16010008. Hematol Rep. 2024. PMID: 38390940 Free PMC article. - Differential Diagnosis: Hepatic Complications in Inborn Errors of Immunity.
Zinser E, Tan KL, Kim DS, O'Brien R, Winstanley A, Yong PFK. Zinser E, et al. J Clin Med. 2023 Dec 3;12(23):7480. doi: 10.3390/jcm12237480. J Clin Med. 2023. PMID: 38068532 Free PMC article. Review. - Severe Combined Immunodeficiency (SCID) and Its New Treatment Modalities.
Wadbudhe AM, Meshram RJ, Tidke SC. Wadbudhe AM, et al. Cureus. 2023 Oct 26;15(10):e47759. doi: 10.7759/cureus.47759. eCollection 2023 Oct. Cureus. 2023. PMID: 38022338 Free PMC article. Review. - Haploidentical Transplant in Radiosensitive Severe Combined Immunodeficiency Disease.
Saini M, Khadwal AR, Roy SS, Pandiarajan V, Malhotra P. Saini M, et al. Cureus. 2023 Sep 13;15(9):e45159. doi: 10.7759/cureus.45159. eCollection 2023 Sep. Cureus. 2023. PMID: 37842439 Free PMC article. - Case report: Artemis deficiency and 3M syndrome-coexistence of two distinct genetic disorders.
Ceylan A, Tekdemir IE, Kocak N, Chinn IK, Orange JS, Artac H. Ceylan A, et al. Front Pediatr. 2023 Jul 13;11:1211254. doi: 10.3389/fped.2023.1211254. eCollection 2023. Front Pediatr. 2023. PMID: 37520055 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Research Materials